文献
J-GLOBAL ID:201802258406741869
整理番号:18A0817678
CK2およびPIMキナーゼの阻害剤としての2,6-二置換ピラジン誘導体の発見【JST・京大機械翻訳】
Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinases
著者 (36件):
Gingipalli Lakshmaiah
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Gingipalli Lakshmaiah
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Block Michael H.
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Block Michael H.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Bao Larry
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Bao Larry
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Cooke Emma
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Cooke Emma
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Dakin Les A.
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Dakin Les A.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Denz Christopher R.
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Denz Christopher R.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Ferguson Andrew D.
(Structure and Biophysics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Ferguson Andrew D.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Johannes Jeffrey W.
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Johannes Jeffrey W.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Larsen Nicholas A.
(Structure and Biophysics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Larsen Nicholas A.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Lyne Paul D.
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Lyne Paul D.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Pontz Timothy W.
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Pontz Timothy W.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Wang Tao
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Wang Tao
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Wu Xiaoyun
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Wu Xiaoyun
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Wu Allan
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Wu Allan
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Zhang Hai-Jun
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Zhang Hai-Jun
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Zheng Xiaolan
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Zheng Xiaolan
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Dowling James E.
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Dowling James E.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
,
Lamb Michelle L.
(Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA)
,
Lamb Michelle L.
(35 Gatehouse Drive, Waltham, MA 02451, USA)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
28
号:
8
ページ:
1336-1341
発行年:
2018年
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)